A patient with bipolar disorder staed lithium therapy. The maximum therapeutic level of lithium in serum is:
First, the core concept here is lithium pharmacology. Lithium is used for bipolar disorder, and its therapeutic range is crucial because it's narrow. The therapeutic levels are typically between 0.6 to 1.2 mmol/L. The maximum therapeutic level would be the upper limit of this range, which is 1.2 mmol/L. Going beyond that increases the risk of toxicity.
Now, why is 1.2 mmol/L correct? Lithium has a narrow therapeutic index, so monitoring is essential. The therapeutic range is where it's effective without causing significant side effects. Levels above 1.5 mmol/L are considered toxic. The mechanism of action isn't fully understood, but it's thought to involve modulation of neurotransmitters and second messenger systems like inositol depletion.
For the incorrect options, if the options were A. 0.5, B. 1.0, C. 1.5, D. 2.0, then A and B are too low to be effective. C is the upper limit of therapeutic, but D is into the toxic range. So D is definitely wrong because it's toxic. C might be a trick option where someone confuses the upper therapeutic with the toxic threshold.
Clinical pearl: Always remember that lithium's therapeutic range is 0.6-1.2 mmol/L. Toxicity starts around 1.5, so maintaining levels within this range is critical. Patients need regular monitoring because even slight increases can lead to toxicity, especially with renal impairment.
Putting it all together, the correct answer is the option that states 1.2 mmol/L. The explanation should clarify the therapeutic range, the risks of exceeding it, and why the other options are incorrect based on their positions relative to this range.
**Core Concept**
Lithium is a first-line treatment for bipolar disorder with a narrow therapeutic index. Its serum concentration must be carefully monitored to balance efficacy and toxicity. The therapeutic range is **0.6–1.2 mmol/L**, with levels above **1.5 mmol/L** indicating toxicity.
**Why the Correct Answer is Right**
The maximum therapeutic lithium level is **1.2 mmol/L**. At this concentration, lithium stabilizes mood by modulating neurotransmitter systems (e.g., GABA, glutamate) and inhibiting inositol monophosphatase, reducing cyclic AMP signaling. Levels above 1.2 mmol/L increase the risk of nephrogenic diabetes insipidus, tremors, and more severe toxicity (e.g., arrhythmias, seizures).
**Why Each Wrong Option is Incorrect**
**Option A:** 0.5 mmol/L is subtherapeutic and ineffective for mood stabilization.
**Option B:** 1.0 mmol/L is within the therapeutic range but not the upper limit.
**Option D:** 1.5 mmol/L exceeds the therapeutic range and enters the toxic zone, risking acute toxicity.
**Clinical Pearl / High-Yield Fact**
Never assume lithium toxicity without serum level confirmation. Classic signs (e.g., coarse tremor, polyuria)